牛牛AI助理已提取核心訊息
Richard I Eisenstadt, the Chief Financial Officer of Altimmune, Inc. [ALT], completed a series of transactions involving the company's common stock over the course of January 30 and January 31, 2024. On January 30, Eisenstadt exercised options to acquire 9,275 shares at no cost and subsequently sold 2,175 shares at $9.80 per share, resulting in a total market value of $21,315. The following day, he acquired an additional 4,621 shares at $2.69 per share through a grant or award. After these transactions, Eisenstadt's direct holdings in Altimmune increased to a total of 45,012 shares of common stock.
Richard I Eisenstadt, the Chief Financial Officer of Altimmune, Inc. [ALT], completed a series of transactions involving the company's common stock over the course of January 30 and January 31, 2024. On January 30, Eisenstadt exercised options to acquire 9,275 shares at no cost and subsequently sold 2,175 shares at $9.80 per share, resulting in a total market value of $21,315. The following day, he acquired an additional 4,621 shares at $2.69 per share through a grant or award. After these transactions, Eisenstadt's direct holdings in Altimmune increased to a total of 45,012 shares of common stock.
Altimmune, Inc. [ALT] 的首席財務官理查德·艾森斯塔特在2024年1月30日和1月31日期間完成了一系列涉及該公司普通股的交易。1月30日，艾森斯塔特行使期權免費收購了9,275股股票，隨後以每股9.80美元的價格出售了2,175股股票，總市值爲21,315美元。第二天，他通過贈款或獎勵以每股2.69美元的價格又收購了4,621股股票。這些交易之後，艾森斯塔特在Altimmune的直接持有量增加到總共45,012股普通股。
Altimmune, Inc. [ALT] 的首席財務官理查德·艾森斯塔特在2024年1月30日和1月31日期間完成了一系列涉及該公司普通股的交易。1月30日，艾森斯塔特行使期權免費收購了9,275股股票，隨後以每股9.80美元的價格出售了2,175股股票，總市值爲21,315美元。第二天，他通過贈款或獎勵以每股2.69美元的價格又收購了4,621股股票。這些交易之後，艾森斯塔特在Altimmune的直接持有量增加到總共45,012股普通股。
有用
沒用